
Cramer’s Morning Take: Eli Lilly 11/24/25
Squawk on the Street
00:00
Investor Reaction and Orforglipron Launch
Discussion of analyst price-target raises and expectations for Lilly's oral GLP-1 Orphoglipron launching next year.
Play episode from 02:19
Transcript


